Let's see... new drug development is at an all time low and the FDA is faced with new responsiblities in tracking the safety of generics being produced from China, counterfeit products, tainted goods, the possiblity of developing new standards for follow on biologics...all in the name of safety.
So the reasonable thing to do is...make it harder for the FDA to track a flood of products from other countries with shady track records?
Of course. Which is why drug reimportation has been reintroduced. Since Congress doesn't really care about drug safety -- except when it comes to hearings -- the legislation designed to make it legal to tranship adulterated and counterfeit drugs through Canada and Europe (read the bill) is now attached to a piece of legislation that would give the FDA the authority to regulate tobacco. (Just what we need, FDA approved Cuban cigars stinking up America.)
See this link to the In Vivo blog about drug running and get the whole story...
So the reasonable thing to do is...make it harder for the FDA to track a flood of products from other countries with shady track records?
Of course. Which is why drug reimportation has been reintroduced. Since Congress doesn't really care about drug safety -- except when it comes to hearings -- the legislation designed to make it legal to tranship adulterated and counterfeit drugs through Canada and Europe (read the bill) is now attached to a piece of legislation that would give the FDA the authority to regulate tobacco. (Just what we need, FDA approved Cuban cigars stinking up America.)
See this link to the In Vivo blog about drug running and get the whole story...
